tiprankstipranks
Curanex Pharmaceuticals Inc. (CURX)
NASDAQ:CURX
US Market
CURX
Curanex Pharmaceuticals Inc.
RESEARCH TOOLSreports

Curanex Pharmaceuticals Inc. (CURX) Income Statement

52 Followers

Curanex Pharmaceuticals Inc. Income Statement

Last quarter (Q4 2025), Curanex Pharmaceuticals Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Curanex Pharmaceuticals Inc.'s net income was $-3.07M. See Curanex Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.24M$ 365.06K$ 19.30K
Depreciation and Amortization
$ 0.00$ 0.00$ 1.81K
EBITDA
$ -4.24M$ -290.39K$ -17.48K
Operating Income
$ -4.24M$ -365.06K$ -19.30K
Other Income/Expenses
$ 13.97K$ 3.56K$ 100.00
Pretax Income
$ -4.23M$ -361.51K$ -19.20K
Net Income
$ -4.23M$ -361.51K$ -19.20K
Per Share Metrics
Basic EPS
$ -0.17$ -0.01$ >-0.01
Diluted EPS
$ -0.17$ -0.01$ >-0.01
Weighted Average Shares Outstanding
 25.50M 27.75M 42.00M
Weighted Average Shares Outstanding (Diluted)
 25.50M 27.75M 42.00M
Currency in USD

Curanex Pharmaceuticals Inc. Earnings and Revenue History